Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2020

Dec 17, 2020

30786_dirs_2020-12-16_9e952b35-8e85-4f48-818d-d36fb931b89c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2020-12-04

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-04 Bio-Rad B Common Stock G 27 $.00 Acquired 298274 Direct
2020-12-04 Bio-Rad B Common Stock G 27 $.00 Acquired 12838 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 418971 Direct
Bio-Rad B Common Stock 4060054 Indirect

Footnotes

F1: The Form 4 is being amended only to add the reporting person's name on the signature line.

F2: The reporting person disclaims beneficial ownership of these shares.

F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.